1289844

Novartis Pharma Schweizerhalle Ag — FEI 3002865753

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pratteln (Switzerland)

Additional Details

Mutual Recognition Agreement (MRA)